Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rebecca Orha
Institution:
Institute of Cancer Research
Observed institutions:
Institute of Cancer Research,
Breast Cancer Now
ORCID:
0000-0002-1740-5616
Observed ORCID:
0000-0002-1740-5616
OpenAlex ID:
A5024778015
Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse
2023
·
Frances K. Turrell
, Rebecca Orha
, et al.
·
Nature Cancer
·
96
PDF
Targeting the activated microenvironment with endosialin (CD248)-directed CAR-T cells ablates perivascular cells to impair tumor growth and metastasis
2024
·
Sarah L Ash
, Rebecca Orha
, et al.
·
Journal for ImmunoTherapy of Cancer
·
43
PDF
Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2023
·
Arany Soosainathan
, Marjan Iravani
, et al.
·
Cancer Research
·
25
PDF
Figure 1 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Figure S4 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
PDF
Figure 3 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Figure S5 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Figure 1 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Figure S3 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
PDF
Figure 2 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Figure 3 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Figure 4 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Figure S3 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Data from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Figure S5 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
PDF
Supplementary Figure S1 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Tables from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Data from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Data from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
PDF
Supplementary Figure S2 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
PDF
Data from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Figure 2 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Supplementary Figure S1 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
PDF
Supplementary Figure S2 from Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers
2024
·
Arany Soosainathan
, Marjan Iravani
, et al.
Show more works
View as search
Works count:
24
Citation count:
164
H-index:
3
I10-index:
3
Year
Topic
Type